Physicians’ Visual Assessments Correlate with Objective Measurements of Postmenopausal VVA Patients Treated with TX-004HR VagiCap

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. PRIM
3. DFTX
4. IBM
5. META
6. MU
7. DPZ
8. ACN
9. ZENA
10. CNC

Go back to Physicians’ Visual Assessments Correlate with Objective Measurements of Postmenopausal VVA Patients Treated with TX-004HR VagiCap

TherapeuticsMD (TXMD) Reports Q4 Loss of $0.10/Share

March 10, 2015 4:11 PM EDT

TherapeuticsMD (NYSE: TXMD) reported Q4 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $4.26 million, versus $2.86 million reported last year.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

... More